Skip to main content

11-11-2019 | Axial spondyloarthritis | Video | Article

Researcher comment: The C-VIEW 48-week interim results

Irene van der Horst Bruinsma discusses the dual benefits of certolizumab pegol for patients with axial spondyloarthritis and a history of acute anterior uveitis (3:32).

Receive weekly updates on the rheumatology news that matters to you


Back to the ACR/ARP 2019 conference hub

Related topics

EULAR 2020 E-Congress hub

Access the latest news and expert video commentary from the EULAR 2020 E-Congress.

Image Credits